The Holy Grail in the brain tumor field, according to Mayfield Clinic neurosurgeon Dr. Ron Warnick, would be a non-invasive test allowing personalized therapy, a way to reliably distinguish if the tumor has grown back, and the ability to make a very specific prognosis. This blood test is still in the research stage. WVXU's Ann Thompson, in "Focus on Technology," reports how it would work and the hope that it carries.
The University of Cincinnati and its academic partners are part a new national collaboration to better understand and treat brain injuries.
One Mind for Research , a non-profit organization based in Seattle, hopes to develop a scientific roadmap for curing brain disease within 10 years. UC and its affiliated institutions have been named one of eight U.S. academic partners.